NX Prenatal to present innovative technology on preterm birth at Philadelphia Prenatal Conference – PR Newswire (press release)

NX Prenatal to present innovative technology on preterm birth at Philadelphia Prenatal Conference
PR Newswire (press release)
NX Prenatal is focused on the development of an exosome-based blood test designed to predict the risk of spontaneous preterm birth as early as 10-12 weeks of pregnancy. This test, the NeXosome Preterm Birth Risk Assay, uses exosomes from the maternal …

Read Original Article: NX Prenatal to present innovative technology on preterm birth at Philadelphia Prenatal Conference – PR Newswire (press release) »

Powered by WPeMatico